G P Garnett1, J M Garcia-Calleja, T Rehle, S Gregson. 1. Department of Infectious Disease Epidemiology, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK. g.garnett@imperial.ac.uk
Abstract
BACKGROUND: Second generation surveillance for HIV aims to improve the validity and utility of routine serial HIV prevalence data. It includes the collection of data on sexual behaviour and sexually transmitted disease prevalence. METHODS: This paper reviews the function of sexual behaviour data in HIV surveillance and the methods used to determine which behaviours are monitored and how changes in behaviour can be assessed. RESULTS: Sexual behaviour data provide a poor predictor of the future spread of HIV, but these data can provide corroboration of changes in HIV incidence and assist in attributing changes to particular aspects of risk. Significance tests should be used to assess changes in behaviour, but this requires transparent reporting of methods and sample sizes. CONCLUSIONS: Collection of behavioural data will provide important retrospective information about the HIV epidemic progress and should not be neglected because of the focus on improving HIV sero-surveillance.
BACKGROUND: Second generation surveillance for HIV aims to improve the validity and utility of routine serial HIV prevalence data. It includes the collection of data on sexual behaviour and sexually transmitted disease prevalence. METHODS: This paper reviews the function of sexual behaviour data in HIV surveillance and the methods used to determine which behaviours are monitored and how changes in behaviour can be assessed. RESULTS: Sexual behaviour data provide a poor predictor of the future spread of HIV, but these data can provide corroboration of changes in HIV incidence and assist in attributing changes to particular aspects of risk. Significance tests should be used to assess changes in behaviour, but this requires transparent reporting of methods and sample sizes. CONCLUSIONS: Collection of behavioural data will provide important retrospective information about the HIV epidemic progress and should not be neglected because of the focus on improving HIV sero-surveillance.
Authors: George P Schmid; Anne Buvé; Peter Mugyenyi; Geoff P Garnett; Richard J Hayes; Brian G Williams; Jesus Garcia Calleja; Kevin M De Cock; James A Whitworth; Saidi H Kapiga; Peter D Ghys; Catherine Hankins; Basia Zaba; Robert Heimer; J Ties Boerma Journal: Lancet Date: 2004-02-07 Impact factor: 79.321
Authors: B Ferry; M Caraël; A Buvé; B Auvert; M Laourou; L Kanhonou; M de Loenzien; E Akam; J Chege; F Kaona Journal: AIDS Date: 2001-08 Impact factor: 4.177
Authors: A J Copas; K Wellings; B Erens; C H Mercer; S McManus; K A Fenton; C Korovessis; W Macdowall; K Nanchahal; A M Johnson Journal: Sex Transm Infect Date: 2002-02 Impact factor: 3.519
Authors: T B Hallett; J Aberle-Grasse; G Bello; L-M Boulos; M P A Cayemittes; B Cheluget; J Chipeta; R Dorrington; S Dube; A K Ekra; J M Garcia-Calleja; G P Garnett; S Greby; S Gregson; J T Grove; S Hader; J Hanson; W Hladik; S Ismail; S Kassim; W Kirungi; L Kouassi; A Mahomva; L Marum; C Maurice; M Nolan; T Rehle; J Stover; N Walker Journal: Sex Transm Infect Date: 2006-04 Impact factor: 3.519
Authors: Françoise Dubois-Arber; André Jeannin; Brenda Spencer; Jean-Pierre Gervasoni; Bertrand Graz; Jonathan Elford; Vivian Hope; France Lert; Helen Ward; Mary Haour-Knipe; Nicola Low; Marita van de Laar Journal: BMC Infect Dis Date: 2010-10-04 Impact factor: 3.090
Authors: Iryna B Zablotska; Andrew Frankland; Martin Holt; John de Wit; Graham Brown; Bruce Maycock; Christopher Fairley; Garrett Prestage Journal: PLoS One Date: 2014-11-19 Impact factor: 3.240
Authors: Elia J Mmbaga; Akhtar Hussain; Germana H Leyna; Carol Holm-Hansen; Kagoma S Mnyika; Noel E Sam; Elise Klouman; Knut-Inge Klepp Journal: AIDS Res Ther Date: 2007-10-16 Impact factor: 2.250
Authors: Timothy B Hallett; Basia Zaba; Jim Todd; Ben Lopman; Wambura Mwita; Sam Biraro; Simon Gregson; J Ties Boerma Journal: PLoS Med Date: 2008-04-08 Impact factor: 11.069